Skip to content
Startups and funding

Isomorphic Labs raises $5B as it looks to take drug candidates to clinical trials.

TechCrunch AIIndependent reporting·
Corroborated event · 2 outlets

Alphabet's Isomorphic Labs closed a $5 billion investment round to accelerate AI drug discovery.

AI brief

Isomorphic Labs, an AI drug-discovery platform spun out of Google's DeepMind in 2021, raised $5 billion in a Series C round.

Written by AI from TechCrunch AI's published text.

Background

From our own funding, model and news trackers, not from the source.

More coverage of this story (1)

Isomorphic Labs raises $5 billion in funding

Isomorphic Labs raises $5 billion in its second mega-round within six months
The Decoder · 17 Nov 2026, 14:57

Primary source

“Isomorphic Labs, the AI drug-discovery platform that was spun out of Google’s DeepMind in 2021, has raised $5 billion in a Series C funding round.”
TechCrunch AI, 17 Nov 2026, 14:50.

Reporting from a publisher outside the organisation being covered.

Read original story ↗